| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_92884d107866ba04b6f1aa4a67eed3ca |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36189
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36062 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0553
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36171
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36175
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36189
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36062 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-36 |
| filingDate |
2019-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34f96b89e95fbe40d941b557987bb963
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c93203d7574c883c5a8caf2341931a0a |
| publicationDate |
2020-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20200132988-A |
| titleOfInvention |
Treatment control and associated systems and methods for treating blood glucose abnormalities, including type 2 diabetes and/or reducing HBA1C levels |
| abstract |
Systems and methods are disclosed for treating patients with blood sugar abnormalities such as type 2 diabetes (T2D) using electrical signals. Exemplary methods for treating a patient include at least one implantable signal transduction device proximate a target location in the patient's spinal cord within the spinal range of about C8 to about T12, based at least in part on the patient's indication for glycemic abnormalities And placing. The method further includes sending an electrical signal to a target location through an implantable signal delivery device, the electrical signal having a frequency in the frequency range of 1.2 kHz to 100 kHz. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022212646-A1 |
| priorityDate |
2018-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |